Probiotics have long been known to improve gastrointestinal health and modulate the immune system. These compete for nutrients and receptors against pathogenic microorganisms and exert antimicrobial activity, activate the immune response and lower the pro-inflammatory response. A balanced gut microbiome is critical as made evident by diseases such as diabetes, cancer, cardiovascular or neurological disorders.

​

​

PROBIOTICS: FIGHTING AN INVISIBLE ENEMY

​

Over 1000 microbial species compose our gut microbiome, varying vastly from individual to individual. Since COVID-19 pandemic was declared, some evidence has emerged suggesting that the use of probiotics could ameliorate COVID-19 related GI symptoms, as well as playing a role in the prophylaxis of this viral disease. In addition, it has also been suggested that COVID-19 symptoms could vary depending on the gut microbiome composition.

​

• Probiotics could reduce the duration of specific respiratory tract viral infections.

• Probiotics lower the pro-inflammatory response, preventing the onset of a cytokine storm
  which ultimately lead to acute lung injury (ALI).

• Probiotics reinforce gut immunity, reducing COVID-19 GI manifestations.

​

TYNDALLIZED PROBIOTICS ARE ADVANTAGEOUS: AN ALTERNATIVE FOR VULNERABLE POPULATIONS

​

Live probiotics are under debate due to that it could put vulnerable populations at risk due to potential bacterial translocations. Tyndallized probiotics are an interesting alternative.

​

• Patented.

• Highly stable, even in liquid formulations.

• High safety profile.

• Exert specific immunomodulatory effects and reduce GI symptoms.